tiprankstipranks
Trending News
More News >
Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
US Market

Mersana Therapeutics (MRSN) Income Statement

Compare
698 Followers

Mersana Therapeutics Income Statement

Last quarter (Q3 2025), Mersana Therapeutics's total revenue was $11.01M, a decrease of -12.61% from the same quarter last year. In Q3, Mersana Therapeutics's net income was $-7.54M. See Mersana Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 40.50M$ 36.85M$ 26.58M$ 43.00K$ 828.00K
Gross Profit
$ 40.50M$ 36.85M$ 26.58M$ 43.00K$ -66.21M
Operating Expenses
$ 113.83M$ 207.81M$ 230.35M$ 168.90M$ 88.94M
Depreciation and Amortization
$ 1.63M$ 1.52M$ 927.00K$ 855.00K$ 1.01M
EBITDA
$ -63.27M$ -166.08M$ -199.96M$ -167.94M$ -87.10M
Operating Income
$ -73.34M$ -170.96M$ -203.77M$ -168.86M$ -155.15M
Other Income/Expenses
$ 4.56M$ -713.00K$ -445.00K$ -1.20M$ 67.10M
Pretax Income
$ -68.77M$ -171.67M$ -204.21M$ -170.06M$ -88.05M
Net Income
$ -69.19M$ -171.67M$ -204.21M$ -170.06M$ -88.05M
Per Share Metrics
Basic EPS
$ -14.12$ -36.96$ -54.51$ -60.24$ -35.80
Diluted EPS
$ -14.12$ -36.96$ -54.51$ -60.24$ -35.80
Weighted Average Shares Outstanding
4.90M----
Weighted Average Shares Outstanding (Diluted)
4.90M----
Currency in USD

Mersana Therapeutics Earnings and Revenue History